A Randomised, Double-blind, Double-dummy, Placebo-controlled,
Multicentre, 6-way Crossover, Single-dose, Phase IIa Study to Evaluate the
Pharmacokinetics and Pharmacodynamics of Different Dry Powder
Inhalation Formulations of AZD3199 Administered via Single Inhalation
Device Compared to AZD3199 Administered via Turbuhaler™1 Inhaler in
Patients With Asthma
